Check out our official website: Check out our Android app: Check out our iOS app: br ----------------------------------------­----------------------------------------­----------------br br A new blood cancer drug, a potential alternative to the common chemotherapy drug melphalan but with fewer side effects, has passed a crucial mid-stage trial, according to a Reuters report. br br The new drug Captisol-enabled melphalan developed by the U.S.-based Spectrum Pharmaceutical does not contain propylene glycol, a chemical believed to be responsible for the side effects of chemotherapy, such as renal and cardiac failure. br br The injectable drug is now being tested in patients with multiple myeloma undergoing stem cell transplants.br br Multiple myeloma is a form of blood cancer caused by the proliferation of cancerous plasma cells. As such malignant cells multiply, the normal blood cells will be crowded out.br br Around 22,000 cases of multiple myeloma are diagnosed in the United States each year.br br ----------------------------------------­----------------------------------------­----------------br br Welcome to TomoNews, where we animate the most entertaining news on the internets. Come here for an animated look at viral headlines, US news, celebrity gossip, salacious scandals, dumb criminals and much more! Subscribe now for daily news animations that will knock your socks off.